Medicine Man Technologies, Inc.
Other OTCTotal Valuation
Medicine Man Technologies, Inc. carries a market capitalization of 802.00, placing it among publicly traded companies globally. Its enterprise value stands at 31.00M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 802.00 |
| Enterprise Value | 31.00M |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | 0.34 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | 1.90 |
| P/OCF Ratio | 2.98 |
Enterprise Valuation
On an enterprise value basis, Medicine Man Technologies, Inc. trades at an EV/EBITDA multiple of 6.75 and an EV/FCF ratio of 0.76. The EV/Sales ratio of 0.34 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 51.68 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.34 |
| EV / EBITDA | 6.75 |
| EV / EBIT | 51.68 |
| EV / FCF | 0.76 |
Financial Position
Medicine Man Technologies, Inc. maintains a current ratio of 2.25, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 286.62, indicating elevated leverage, while an interest coverage ratio of 0.28 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.25 |
| Quick Ratio | 0.93 |
| Debt / Equity | 286.62 |
| Debt / EBITDA | N/A |
| Interest Coverage | 0.28 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -16.09 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 14.15 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.64 |
Taxes
Over the trailing twelve months, Medicine Man Technologies, Inc. has paid 9.94M in income taxes, reflecting an effective tax rate of 106.30.
| Income Tax | 9.94M |
| Effective Tax Rate | 106.30 |
Stock Price Statistics
Medicine Man Technologies, Inc.'s stock has declined approximately -99.93333% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | -99.93333% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Medicine Man Technologies, Inc. generated 90.07M in revenue and converted that into -29.69M in net income, yielding earnings per share of -0.38. EBITDA reached 4.59M, while operating income came in at -5.52M.
| Revenue | 90.07M |
| Gross Profit | 28.47M |
| Operating Income | -5.52M |
| Pretax Income | -19.75M |
| Net Income | -29.69M |
| EBITDA | 4.59M |
| EBIT | -5.52M |
| Earnings Per Share (EPS) | -0.38 |
Cash Flow
Medicine Man Technologies, Inc. produced 10.40M in operating cash flow over the past twelve months. After subtracting -5.91M in capital expenditures, free cash flow totaled 4.49M - equivalent to 0.06 per share.
| Operating Cash Flow | 10.40M |
| Capital Expenditures | -5.91M |
| Free Cash Flow | 4.49M |
| FCF Per Share | 0.06 |
Margins
Medicine Man Technologies, Inc. operates with a gross margin of 31.61, reflecting its pricing power and cost economics. The operating margin of -6.12 and net profit margin of -32.96 provide insight into operational efficiency.
| Gross Margin | 31.61 |
| Operating Margin | -6.12 |
| Pretax Margin | -21.93 |
| Profit Margin | -32.96 |
| EBITDA Margin | 5.10 |
Dividends & Yields
The company's payout ratio of 11.27 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | 11.27 |
| Shareholder Yield | 16.48 |
| FCF Yield | 52.60 |
Scores
Medicine Man Technologies, Inc. posts an Altman Z-Score of 2.46, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.46 |